{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T13:22:37Z","timestamp":1784899357114,"version":"3.55.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T00:00:00Z","timestamp":1610150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T00:00:00Z","timestamp":1610150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s40618-020-01494-0","type":"journal-article","created":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T20:08:02Z","timestamp":1610222882000},"page":"1753-1765","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Lipocalin-2: a role in hepatic gluconeogenesis via AMP-activated protein kinase (AMPK)"],"prefix":"10.1007","volume":"44","author":[{"given":"W-X.","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L-J.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8382-5328","authenticated-orcid":false,"given":"S-D.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S-G.","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,9]]},"reference":[{"key":"1494_CR1","unstructured":"Organization WH (2016) Global Report on Diabetes. Working Papers"},{"issue":"5","key":"1494_CR2","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/dmrr.2827","volume":"32","author":"J Weng","year":"2016","unstructured":"Weng J, Ji L, Jia W, Lu J, Zhou Z, Zou D, Zhu D, Chen L, Chen L, Guo L, Guo X, Ji Q, Li Q, Li X, Liu J, Ran X, Shan Z, Shi L, Song G, Yang L, Yang Y, Yang W, Chinese Diabetes S (2016) Standards of care for type 2 diabetes in China. Diabetes Metab Res Rev 32(5):442\u2013458. https:\/\/doi.org\/10.1002\/dmrr.2827","journal-title":"Diabetes Metab Res Rev"},{"issue":"9","key":"1494_CR3","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1001\/jama.2013.168118","volume":"310","author":"Y Xu","year":"2013","unstructured":"Xu Y, Wang L, He J, Bi Y, Li M, Wang T, Wang L, Jiang Y, Dai M, Lu J, Xu M, Li Y, Hu N, Li J, Mi S, Chen CS, Li G, Mu Y, Zhao J, Kong L, Chen J, Lai S, Wang W, Zhao W, Ning G, China Noncommunicable Disease Surveillance G (2013) Prevalence and control of diabetes in Chinese adults. JAMA 310(9):948\u2013959. https:\/\/doi.org\/10.1001\/jama.2013.168118","journal-title":"JAMA"},{"issue":"14","key":"1494_CR4","doi-asserted-by":"publisher","first-page":"8466","DOI":"10.1073\/pnas.1032913100","volume":"100","author":"ME Patti","year":"2003","unstructured":"Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, Miyazaki Y, Kohane I, Costello M, Saccone R, Landaker EJ, Goldfine AB, Mun E, DeFronzo R, Finlayson J, Kahn CR, Mandarino LJ (2003) Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci USA 100(14):8466\u20138471. https:\/\/doi.org\/10.1073\/pnas.1032913100","journal-title":"Proc Natl Acad Sci USA"},{"issue":"14","key":"1494_CR5","doi-asserted-by":"publisher","first-page":"10425","DOI":"10.1016\/S0021-9258(18)82217-7","volume":"268","author":"L Kjeldsen","year":"1993","unstructured":"Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N (1993) Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 268(14):10425\u201310432","journal-title":"J Biol Chem"},{"issue":"7","key":"1494_CR6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1023\/a:1003708808934","volume":"31","author":"A Friedl","year":"1999","unstructured":"Friedl A, Stoesz SP, Buckley P, Gould MN (1999) Neutrophil gelatinase-associated lipocalin in normal and neoplastic human. Tissues cell type-specific pattern of expression. Histochem J 31(7):433\u2013441. https:\/\/doi.org\/10.1023\/a:1003708808934","journal-title":"Histochem J"},{"issue":"5","key":"1494_CR7","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/s1097-2765(02)00710-4","volume":"10","author":"J Yang","year":"2002","unstructured":"Yang J, Goetz D, Li JY, Wang W, Mori K, Setlik D, Du T, Erdjument-Bromage H, Tempst P, Strong R, Barasch J (2002) An iron delivery pathway mediated by a lipocalin. Mol Cell 10(5):1045\u20131056. https:\/\/doi.org\/10.1016\/s1097-2765(02)00710-4","journal-title":"Mol Cell"},{"issue":"50","key":"1494_CR8","doi-asserted-by":"publisher","first-page":"25901","DOI":"10.1074\/jbc.M116.759183","volume":"291","author":"RR Shields-Cutler","year":"2016","unstructured":"Shields-Cutler RR, Crowley JR, Miller CD, Stapleton AE, Cui W, Henderson JP (2016) Human metabolome-derived cofactors are required for the antibacterial activity of siderocalin in urine. J Biol Chem 291(50):25901\u201325910. https:\/\/doi.org\/10.1074\/jbc.M116.759183","journal-title":"J Biol Chem"},{"issue":"1","key":"1494_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1373\/clinchem.2006.075614","volume":"53","author":"Y Wang","year":"2007","unstructured":"Wang Y, Lam KS, Kraegen EW, Sweeney G, Zhang J, Tso AW, Chow WS, Wat NM, Xu JY, Hoo RL, Xu A (2007) Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin Chem 53(1):34\u201341. https:\/\/doi.org\/10.1373\/clinchem.2006.075614","journal-title":"Clin Chem"},{"issue":"Suppl 2","key":"1494_CR10","doi-asserted-by":"publisher","first-page":"S362","DOI":"10.2337\/dc09-S340","volume":"32","author":"E Esteve","year":"2009","unstructured":"Esteve E, Ricart W, Fernandez-Real JM (2009) Adipocytokines and insulin resistance: the possible role of lipocalin-2, retinol binding protein-4, and adiponectin. Diabetes Care 32(Suppl 2):S362-367. https:\/\/doi.org\/10.2337\/dc09-S340","journal-title":"Diabetes Care"},{"key":"1494_CR11","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3389\/fphys.2016.00430","volume":"7","author":"A Asimakopoulou","year":"2016","unstructured":"Asimakopoulou A, Weiskirchen S, Weiskirchen R (2016) Lipocalin 2 (LCN2) expression in hepatic malfunction and therapy. Front Physiol 7:430. https:\/\/doi.org\/10.3389\/fphys.2016.00430","journal-title":"Front Physiol"},{"key":"1494_CR12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.mce.2016.03.011","volume":"427","author":"PG Kamble","year":"2016","unstructured":"Kamble PG, Pereira MJ, Sidibeh CO, Amini S, Sundbom M, Borjesson JL, Eriksson JW (2016) Lipocalin 2 produces insulin resistance and can be upregulated by glucocorticoids in human adipose tissue. Mol Cell Endocrinol 427:124\u2013132. https:\/\/doi.org\/10.1016\/j.mce.2016.03.011","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"1494_CR13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/dmrr.2493","volume":"30","author":"G Wu","year":"2014","unstructured":"Wu G, Li H, Zhou M, Fang Q, Bao Y, Xu A, Jia W (2014) Mechanism and clinical evidence of lipocalin-2 and adipocyte fatty acid-binding protein linking obesity and atherosclerosis. Diabetes Metab Res Rev 30(6):447\u2013456. https:\/\/doi.org\/10.1002\/dmrr.2493","journal-title":"Diabetes Metab Res Rev"},{"issue":"4","key":"1494_CR14","doi-asserted-by":"publisher","first-page":"872","DOI":"10.2337\/db09-1541","volume":"59","author":"IK Law","year":"2010","unstructured":"Law IK, Xu A, Lam KS, Berger T, Mak TW, Vanhoutte PM, Liu JT, Sweeney G, Zhou M, Yang B, Wang Y (2010) Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesity. Diabetes 59(4):872\u2013882. https:\/\/doi.org\/10.2337\/db09-1541","journal-title":"Diabetes"},{"issue":"1","key":"1494_CR15","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1161\/01.ATV.0000193567.88685.f4","volume":"26","author":"AL Hemdahl","year":"2006","unstructured":"Hemdahl AL, Gabrielsen A, Zhu C, Eriksson P, Hedin U, Kastrup J, Thoren P, Hansson GK (2006) Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction. Arterioscler Thromb Vasc Biol 26(1):136\u2013142. https:\/\/doi.org\/10.1161\/01.ATV.0000193567.88685.f4","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1494_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1475-2840-11-11","volume":"11","author":"Y Huang","year":"2012","unstructured":"Huang Y, Yang Z, Ye Z, Li Q, Wen J, Tao X, Chen L, He M, Wang X, Lu B, Zhang Z, Zhang W, Qu S, Hu R (2012) Lipocalin-2, glucose metabolism and chronic low-grade systemic inflammation in Chinese people. Cardiovasc Diabetol 11:11. https:\/\/doi.org\/10.1186\/1475-2840-11-11","journal-title":"Cardiovasc Diabetol"},{"issue":"10","key":"1494_CR17","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.2337\/db07-0007","volume":"56","author":"QW Yan","year":"2007","unstructured":"Yan QW, Yang Q, Mody N, Graham TE, Hsu CH, Xu Z, Houstis NE, Kahn BB, Rosen ED (2007) The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes 56(10):2533\u20132540. https:\/\/doi.org\/10.2337\/db07-0007","journal-title":"Diabetes"},{"issue":"8","key":"1494_CR18","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3109\/1354750X.2015.1123354","volume":"20","author":"V Abella","year":"2015","unstructured":"Abella V, Scotece M, Conde J, Gomez R, Lois A, Pino J, Gomez-Reino JJ, Lago F, Mobasheri A, Gualillo O (2015) The potential of lipocalin-2\/NGAL as biomarker for inflammatory and metabolic diseases. Biomarkers 20(8):565\u2013571. https:\/\/doi.org\/10.3109\/1354750X.2015.1123354","journal-title":"Biomarkers"},{"key":"1494_CR19","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.mce.2016.04.006","volume":"430","author":"YK Chan","year":"2016","unstructured":"Chan YK, Sung HK, Jahng JW, Kim GH, Han M, Sweeney G (2016) Lipocalin-2 inhibits autophagy and induces insulin resistance in H9c2 cells. Mol Cell Endocrinol 430:68\u201376. https:\/\/doi.org\/10.1016\/j.mce.2016.04.006","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"1494_CR20","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00592-012-0373-6","volume":"50","author":"HO El-Mesallamy","year":"2013","unstructured":"El-Mesallamy HO, Hamdy NM, Sallam AA (2013) Effect of obesity and glycemic control on serum lipocalins and insulin-like growth factor axis in type 2 diabetic patients. Acta Diabetol 50(5):679\u2013685. https:\/\/doi.org\/10.1007\/s00592-012-0373-6","journal-title":"Acta Diabetol"},{"issue":"2","key":"1494_CR21","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/iub.1594","volume":"69","author":"NM Rashad","year":"2017","unstructured":"Rashad NM, El-Shal AS, Etewa RL, Wadea FM (2017) Lipocalin-2 expression and serum levels as early predictors of type 2 diabetes mellitus in obese women. IUBMB Life 69(2):88\u201397. https:\/\/doi.org\/10.1002\/iub.1594","journal-title":"IUBMB Life"},{"issue":"5","key":"1494_CR22","doi-asserted-by":"publisher","first-page":"e96997","DOI":"10.1371\/journal.pone.0096997","volume":"9","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Foncea R, Deis JA, Guo H, Bernlohr DA, Chen X (2014) Lipocalin 2 expression and secretion is highly regulated by metabolic stress, cytokines, and nutrients in adipocytes. PLoS ONE 9(5):e96997. https:\/\/doi.org\/10.1371\/journal.pone.0096997","journal-title":"PLoS ONE"},{"issue":"5","key":"1494_CR23","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1080\/07853890510037383","volume":"37","author":"H Yki-Jarvinen","year":"2005","unstructured":"Yki-Jarvinen H (2005) Fat in the liver and insulin resistance. Ann Med 37(5):347\u2013356. https:\/\/doi.org\/10.1080\/07853890510037383","journal-title":"Ann Med"},{"issue":"6865","key":"1494_CR24","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/414821a","volume":"414","author":"DE Moller","year":"2001","unstructured":"Moller DE (2001) New drug targets for type 2 diabetes and the metabolic syndrome. Nature 414(6865):821\u2013827. https:\/\/doi.org\/10.1038\/414821a","journal-title":"Nature"},{"issue":"3","key":"1494_CR25","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1210\/jc.2005-1159","volume":"91","author":"A Gastaldelli","year":"2006","unstructured":"Gastaldelli A, Miyazaki Y, Pettiti M, Santini E, Ciociaro D, Defronzo RA, Ferrannini E (2006) The effect of rosiglitazone on the liver: decreased gluconeogenesis in patients with type 2 diabetes. J Clin Endocrinol Metab 91(3):806\u2013812. https:\/\/doi.org\/10.1210\/jc.2005-1159","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1494_CR26","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.1210\/en.2009-0462","volume":"150","author":"BS Muhlhausler","year":"2009","unstructured":"Muhlhausler BS, Morrison JL, McMillen IC (2009) Rosiglitazone increases the expression of peroxisome proliferator-activated receptor-gamma target genes in adipose tissue, liver, and skeletal muscle in the sheep fetus in late gestation. Endocrinology 150(9):4287\u20134294. https:\/\/doi.org\/10.1210\/en.2009-0462","journal-title":"Endocrinology"},{"issue":"7","key":"1494_CR27","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.dld.2008.11.012","volume":"41","author":"H Yadav","year":"2009","unstructured":"Yadav H, Jain S, Yadav M, Sinha PR, Prasad GB, Marotta F (2009) Epigenomic derangement of hepatic glucose metabolism by feeding of high fructose diet and its prevention by Rosiglitazone in rats. Dig Liver Dis 41(7):500\u2013508. https:\/\/doi.org\/10.1016\/j.dld.2008.11.012","journal-title":"Dig Liver Dis"},{"issue":"35","key":"1494_CR28","doi-asserted-by":"publisher","first-page":"13106","DOI":"10.1074\/jbc.RA119.008649","volume":"294","author":"M Saline","year":"2019","unstructured":"Saline M, Badertscher L, Wolter M, Lau R, Gunnarsson A, Jacso T, Norris T, Ottmann C, Snijder A (2019) AMPK and AKT protein kinases hierarchically phosphorylate the N-terminus of the FOXO1 transcription factor, modulating interactions with 14-3-3 proteins. J Biol Chem 294(35):13106\u201313116. https:\/\/doi.org\/10.1074\/jbc.RA119.008649","journal-title":"J Biol Chem"},{"issue":"1","key":"1494_CR29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.febslet.2007.11.025","volume":"582","author":"J Nakae","year":"2008","unstructured":"Nakae J, Oki M, Cao Y (2008) The FoxO transcription factors and metabolic regulation. FEBS Lett 582(1):54\u201367. https:\/\/doi.org\/10.1016\/j.febslet.2007.11.025","journal-title":"FEBS Lett"},{"issue":"9","key":"1494_CR30","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/ppul.22919","volume":"49","author":"H Awad","year":"2014","unstructured":"Awad H, Nolette N, Hinton M, Dakshinamurti S (2014) AMPK and FoxO1 regulate catalase expression in hypoxic pulmonary arterial smooth muscle. Pediatr Pulmonol 49(9):885\u2013897. https:\/\/doi.org\/10.1002\/ppul.22919","journal-title":"Pediatr Pulmonol"},{"issue":"9","key":"1494_CR31","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1172\/JCI12876","volume":"108","author":"J Nakae","year":"2001","unstructured":"Nakae J, Kitamura T, Silver DL, Accili D (2001) The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J Clin Invest 108(9):1359\u20131367. https:\/\/doi.org\/10.1172\/JCI12876","journal-title":"J Clin Invest"},{"issue":"3","key":"1494_CR32","first-page":"9785","volume":"7","author":"MM Rahman","year":"2015","unstructured":"Rahman MM, Hasan MM, MasudRana HI, Rahman MS, Asaduzzaman M, Munira S, Biswas S, Siddique MAH, Khan MH (2015) Elevated serum lipocalin-2 is a risk factor of insulin resistance and for the progression of impaired glucose to type 2 diabetes in Bangladeshi population. Intern J Pharm Technol 7(3):9785\u20139794","journal-title":"Intern J Pharm Technol"},{"issue":"6","key":"1494_CR33","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1073\/pnas.0510847103","volume":"103","author":"T Berger","year":"2006","unstructured":"Berger T, Togawa A, Duncan GS, Elia AJ, You-Ten A, Wakeham A, Fong HE, Cheung CC, Mak TW (2006) Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc Natl Acad Sci USA 103(6):1834\u20131839. https:\/\/doi.org\/10.1073\/pnas.0510847103","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"1494_CR34","doi-asserted-by":"publisher","first-page":"390","DOI":"10.2337\/diabetes.55.02.06.db05-0686","volume":"55","author":"JE Ayala","year":"2006","unstructured":"Ayala JE, Bracy DP, McGuinness OP, Wasserman DH (2006) Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse. Diabetes 55(2):390\u2013397. https:\/\/doi.org\/10.2337\/diabetes.55.02.06.db05-0686","journal-title":"Diabetes"},{"issue":"10","key":"1494_CR35","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1172\/JCI15880","volume":"110","author":"K Miyake","year":"2002","unstructured":"Miyake K, Ogawa W, Matsumoto M, Nakamura T, Sakaue H, Kasuga M (2002) Hyperinsulinemia, glucose intolerance, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liver. J Clin Invest 110(10):1483\u20131491. https:\/\/doi.org\/10.1172\/JCI15880","journal-title":"J Clin Invest"},{"issue":"5","key":"1494_CR36","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1007\/s00125-018-4562-x","volume":"61","author":"X Qi","year":"2018","unstructured":"Qi X, Guo Y, Song Y, Yu C, Zhao L, Fang L, Kong D, Zhao J, Gao L (2018) Follicle-stimulating hormone enhances hepatic gluconeogenesis by GRK2-mediated AMPK hyperphosphorylation at Ser485 in mice. Diabetologia 61(5):1180\u20131192. https:\/\/doi.org\/10.1007\/s00125-018-4562-x","journal-title":"Diabetologia"},{"issue":"2","key":"1494_CR37","doi-asserted-by":"publisher","first-page":"306","DOI":"10.2337\/db07-0381","volume":"57","author":"YD Kim","year":"2008","unstructured":"Kim YD, Park KG, Lee YS, Park YY, Kim DK, Nedumaran B, Jang WG, Cho WJ, Ha J, Lee IK, Lee CH, Choi HS (2008) Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP. Diabetes 57(2):306\u2013314. https:\/\/doi.org\/10.2337\/db07-0381","journal-title":"Diabetes"},{"issue":"46","key":"1494_CR38","doi-asserted-by":"publisher","first-page":"36324","DOI":"10.1074\/jbc.M003616200","volume":"275","author":"D Schmoll","year":"2000","unstructured":"Schmoll D, Walker KS, Alessi DR, Grempler R, Burchell A, Guo S, Walther R, Unterman TG (2000) Regulation of glucose-6-phosphatase gene expression by protein kinase B\u03b1 and the forkhead transcription factor FKHR. J Biol Chem 275(46):36324\u201336333. https:\/\/doi.org\/10.1074\/jbc.M003616200","journal-title":"J Biol Chem"},{"issue":"25","key":"1494_CR39","doi-asserted-by":"publisher","first-page":"22675","DOI":"10.1074\/jbc.M102422200","volume":"276","author":"PS Lechner","year":"2001","unstructured":"Lechner PS, Croniger CM, Hakimi P, Millward C, Fekter C, Yun JS, Hanson RW (2001) The use of transgenic mice to analyze the role of accessory factor two in the regulation of phosphoenolpyruvate carboxykinase (GTP) gene transcription during diabetes. J Biol Chem 276(25):22675","journal-title":"J Biol Chem"},{"key":"1494_CR40","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.mce.2017.02.015","volume":"446","author":"Y Li","year":"2017","unstructured":"Li Y, Wang L, Zhou L, Song Y, Ma S, Yu C, Zhao J, Xu C, Gao L (2017) Thyroid stimulating hormone increases hepatic gluconeogenesis via CRTC2. Mol Cell Endocrinol 446:70\u201380. https:\/\/doi.org\/10.1016\/j.mce.2017.02.015","journal-title":"Mol Cell Endocrinol"},{"issue":"8","key":"1494_CR41","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.2337\/db05-1188","volume":"55","author":"M Zang","year":"2006","unstructured":"Zang M, Xu S, Maitland-Toolan KA, Zuccollo A, Hou X, Jiang B, Wierzbicki M, Verbeuren TJ, Cohen RA (2006) Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes 55(8):2180\u20132191. https:\/\/doi.org\/10.2337\/db05-1188","journal-title":"Diabetes"},{"issue":"4","key":"1494_CR42","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.bbrc.2006.10.124","volume":"351","author":"E Inoue","year":"2006","unstructured":"Inoue E, Yamauchi J (2006) AMP-activated protein kinase regulates PEPCK gene expression by direct phosphorylation of a novel zinc finger transcription factor. Biochem Biophys Res Commun 351(4):793\u2013799. https:\/\/doi.org\/10.1016\/j.bbrc.2006.10.124","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"1494_CR43","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1017\/S0007114511005563","volume":"108","author":"PV Nerurkar","year":"2012","unstructured":"Nerurkar PV, Nishioka A, Eck PO, Johns LM, Volper E, Nerurkar VR (2012) Regulation of glucose metabolism via hepatic forkhead transcription factor 1 (FoxO1) by Morinda citrifolia (noni) in high-fat diet-induced obese mice. Br J Nutr 108(2):218\u2013228. https:\/\/doi.org\/10.1017\/S0007114511005563","journal-title":"Br J Nutr"},{"issue":"2","key":"1494_CR44","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/ajcp\/105.2.149","volume":"105","author":"DB Sacks","year":"1996","unstructured":"Sacks DB, McDonald JM (1996) The pathogenesis of type II diabetes mellitus. A polygenic disease. Am J Clin Pathol 105(2):149\u2013156. https:\/\/doi.org\/10.1093\/ajcp\/105.2.149","journal-title":"Am J Clin Pathol"},{"issue":"38","key":"1494_CR45","doi-asserted-by":"publisher","first-page":"22565","DOI":"10.1074\/jbc.270.38.22565","volume":"270","author":"Q Liu","year":"1995","unstructured":"Liu Q, Nilsen-Hamilton M (1995) Identification of a new acute phase protein. J Biol Chem 270(38):22565\u201322570. https:\/\/doi.org\/10.1074\/jbc.270.38.22565","journal-title":"J Biol Chem"},{"issue":"2","key":"1494_CR46","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/SHK.0b013e31823918c2","volume":"37","author":"S Sultan","year":"2012","unstructured":"Sultan S, Pascucci M, Ahmad S, Malik IA, Bianchi A, Ramadori P, Ahmad G, Ramadori G (2012) LIPOCALIN-2 is a major acute-phase protein in a rat and mouse model of sterile abscess. Shock 37(2):191\u2013196. https:\/\/doi.org\/10.1097\/SHK.0b013e31823918c2","journal-title":"Shock"},{"issue":"5","key":"1494_CR47","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.chom.2009.03.011","volume":"5","author":"M Raffatellu","year":"2009","unstructured":"Raffatellu M, George MD, Akiyama Y, Hornsby MJ, Nuccio SP, Paixao TA, Butler BP, Chu H, Santos RL, Berger T, Mak TW, Tsolis RM, Bevins CL, Solnick JV, Dandekar S, Baumler AJ (2009) Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe 5(5):476\u2013486. https:\/\/doi.org\/10.1016\/j.chom.2009.03.011","journal-title":"Cell Host Microbe"},{"issue":"6","key":"1494_CR48","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1210\/me.2007-0420","volume":"22","author":"J Zhang","year":"2008","unstructured":"Zhang J, Wu Y, Zhang Y, Leroith D, Bernlohr DA, Chen X (2008) The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages. Mol Endocrinol 22(6):1416\u20131426. https:\/\/doi.org\/10.1210\/me.2007-0420","journal-title":"Mol Endocrinol"},{"key":"1494_CR49","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bbi.2014.12.026","volume":"46","author":"L Gouweleeuw","year":"2015","unstructured":"Gouweleeuw L, Naude PJ, Rots M, DeJongste MJ, Eisel UL, Schoemaker RG (2015) The role of neutrophil gelatinase associated lipocalin (NGAL) as biological constituent linking depression and cardiovascular disease. Brain Behav Immun 46:23\u201332. https:\/\/doi.org\/10.1016\/j.bbi.2014.12.026","journal-title":"Brain Behav Immun"},{"issue":"2","key":"1494_CR50","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1055\/s-0032-1331696","volume":"121","author":"T Auguet","year":"2013","unstructured":"Auguet T, Terra X, Quintero Y, Martinez S, Manresa N, Porras JA, Aguilar C, Orellana-Gavalda JM, Hernandez M, Sabench F, Lucas A, Pellitero S, Del Castillo D, Richart C (2013) Liver lipocalin 2 expression in severely obese women with non alcoholic fatty liver disease. Exp Clin Endocrinol Diabetes 121(2):119\u2013124. https:\/\/doi.org\/10.1055\/s-0032-1331696","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"3","key":"1494_CR51","doi-asserted-by":"publisher","first-page":"E214","DOI":"10.1152\/ajpendo.1979.237.3.E214","volume":"237","author":"RA DeFronzo","year":"1979","unstructured":"DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237(3):E214-223. https:\/\/doi.org\/10.1152\/ajpendo.1979.237.3.E214","journal-title":"Am J Physiol"},{"issue":"6","key":"1494_CR52","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.2337\/db09-1735","volume":"59","author":"H Guo","year":"2010","unstructured":"Guo H, Jin D, Zhang Y, Wright W, Bazuine M, Brockman DA, Bernlohr DA, Chen X (2010) Lipocalin-2 deficiency impairs thermogenesis and potentiates diet-induced insulin resistance in mice. Diabetes 59(6):1376\u20131385. https:\/\/doi.org\/10.2337\/db09-1735","journal-title":"Diabetes"},{"issue":"5","key":"1494_CR53","doi-asserted-by":"publisher","first-page":"E825","DOI":"10.1152\/ajpendo.00147.2011","volume":"301","author":"LS Jun","year":"2011","unstructured":"Jun LS, Siddall CP, Rosen ED (2011) A minor role for lipocalin 2 in high-fat diet-induced glucose intolerance. Am J Physiol Endocrinol Metab 301(5):E825-835. https:\/\/doi.org\/10.1152\/ajpendo.00147.2011","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5\u20136","key":"1494_CR54","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s003600000113","volume":"170","author":"DR Sartori","year":"2000","unstructured":"Sartori DR, Garofalo MA, Roselino JE, Kettelhut IC, Migliorini RH (2000) Gluconeogenesis and P-enolpyruvate carboxykinase in liver and kidney of long-term fasted quails. J Comp Physiol B 170(5\u20136):373\u2013377. https:\/\/doi.org\/10.1007\/s003600000113","journal-title":"J Comp Physiol B"},{"issue":"2","key":"1494_CR55","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1248\/bpb.33.325","volume":"33","author":"SJ Kim","year":"2010","unstructured":"Kim SJ, Yuan HD, Chung SH (2010) Ginsenoside Rg1 suppresses hepatic glucose production via AMP-activated protein kinase in HepG2 cells. Biol Pharm Bull 33(2):325\u2013328. https:\/\/doi.org\/10.1248\/bpb.33.325","journal-title":"Biol Pharm Bull"},{"issue":"3","key":"1494_CR56","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.bbrc.2015.08.126","volume":"466","author":"K Lee","year":"2015","unstructured":"Lee K, Ochi E, Song H, Nakazato K (2015) Activation of AMP-activated protein kinase induce expression of FoxO1, FoxO3a, and myostatin after exercise-induced muscle damage. Biochem Biophys Res Commun 466(3):289\u2013294. https:\/\/doi.org\/10.1016\/j.bbrc.2015.08.126","journal-title":"Biochem Biophys Res Commun"},{"issue":"19","key":"1494_CR57","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.1111\/febs.12949","volume":"281","author":"H Yun","year":"2014","unstructured":"Yun H, Park S, Kim MJ, Yang WK, Im DU, Yang KR, Hong J, Choe W, Kang I, Kim SS, Ha J (2014) AMP-activated protein kinase mediates the antioxidant effects of resveratrol through regulation of the transcription factor FoxO1. FEBS J 281(19):4421\u20134438. https:\/\/doi.org\/10.1111\/febs.12949","journal-title":"FEBS J"},{"key":"1494_CR58","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2147\/DMSO.S43731","volume":"7","author":"KA Coughlan","year":"2014","unstructured":"Coughlan KA, Valentine RJ, Ruderman NB, Saha AK (2014) AMPK activation: a therapeutic target for type 2 diabetes? Diabetes Metab Syndr Obes 7:241\u2013253. https:\/\/doi.org\/10.2147\/DMSO.S43731","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"6","key":"1494_CR59","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.cmet.2014.09.013","volume":"20","author":"DG Hardie","year":"2014","unstructured":"Hardie DG (2014) AMPK\u2014sensing energy while talking to other signaling pathways. Cell Metab 20(6):939\u2013952. https:\/\/doi.org\/10.1016\/j.cmet.2014.09.013","journal-title":"Cell Metab"},{"issue":"1","key":"1494_CR60","doi-asserted-by":"publisher","first-page":"E23","DOI":"10.1152\/ajpendo.2001.280.1.E23","volume":"280","author":"G Boden","year":"2001","unstructured":"Boden G, Chen X, Stein TP (2001) Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 280(1):E23-30. https:\/\/doi.org\/10.1152\/ajpendo.2001.280.1.E23","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5","key":"1494_CR61","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.cmet.2009.03.012","volume":"9","author":"BB Zhang","year":"2009","unstructured":"Zhang BB, Zhou G, Li C (2009) AMPK: an emerging drug target for diabetes and the metabolic syndrome. Cell Metab 9(5):407\u2013416. https:\/\/doi.org\/10.1016\/j.cmet.2009.03.012","journal-title":"Cell Metab"},{"issue":"19","key":"1494_CR62","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/j.cub.2007.08.047","volume":"17","author":"EL Greer","year":"2007","unstructured":"Greer EL, Dowlatshahi D, Banko MR, Villen J, Hoang K, Blanchard D, Gygi SP, Brunet A (2007) An AMPK-FOXO pathway mediates longevity induced by a novel method of dietary restriction in C. elegans. Curr Biol 17(19):1646\u20131656. https:\/\/doi.org\/10.1016\/j.cub.2007.08.047","journal-title":"Curr Biol"},{"issue":"6","key":"1494_CR63","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/s0092-8674(00)80595-4","volume":"96","author":"A Brunet","year":"1999","unstructured":"Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96(6):857\u2013868. https:\/\/doi.org\/10.1016\/s0092-8674(00)80595-4","journal-title":"Cell"},{"issue":"5","key":"1494_CR64","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1073\/pnas.0406789102","volume":"102","author":"H Huang","year":"2005","unstructured":"Huang H, Regan KM, Wang F, Wang D, Smith DI, Van Deursen JMA, Tindall DJ (2005) Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. Proc Natl Acad USA 102(5):1649\u20131654","journal-title":"Proc Natl Acad USA"},{"issue":"5","key":"1494_CR65","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.cmet.2011.09.012","volume":"14","author":"AS Banks","year":"2011","unstructured":"Banks AS, Kim-Muller JY, Mastracci TL, Kofler NM, Qiang L, Haeusler RA, Jurczak MJ, Laznik D, Heinrich G, Samuel VT, Shulman GI, Papaioannou VE, Accili D (2011) Dissociation of the glucose and lipid regulatory functions of FoxO1 by targeted knockin of acetylation-defective alleles in mice. Cell Metab 14(5):587\u2013597. https:\/\/doi.org\/10.1016\/j.cmet.2011.09.012","journal-title":"Cell Metab"},{"issue":"2","key":"1494_CR66","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/MPA.0000000000001239","volume":"48","author":"Z Jiang","year":"2019","unstructured":"Jiang Z, Xing B, Feng Z, Ma J, Ma X, Hua X (2019) Menin upregulates FOXO1 protein stability by repressing Skp2-mediated degradation in \u03b2 cells. Pancreas 48(2):267\u2013274. https:\/\/doi.org\/10.1097\/MPA.0000000000001239","journal-title":"Pancreas"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01494-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-020-01494-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01494-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T11:12:05Z","timestamp":1626433925000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-020-01494-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,9]]},"references-count":66,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["1494"],"URL":"https:\/\/doi.org\/10.1007\/s40618-020-01494-0","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,9]]},"assertion":[{"value":"13 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors report no conflicts of interest in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of Shandong First Medical University (No. GZR2020-020-01).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}